Please try another search
For the fiscal year ended 30 June 2018, Genera Biosystems Limited revenues increased 11% to A$889K. Net loss increased 17% to A$4.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Finance Costs increase of 22% to A$2.4M (expense), Employee Benefits Expenses increase of 13% to A$1.6M (expense), Professional Fees increase from A$158K to A$332K (expense).
Period Ending: | Jun 30, 2018 | Dec 31, 2017 | Jun 30, 2017 | Dec 31, 2016 |
---|---|---|---|---|
Total Revenue | 0.32 | 0.57 | 0.35 | 0.45 |
Gross Profit | 0.15 | 0.3 | 0.2 | 0.2 |
Operating Income | -1.09 | -1.02 | -1.07 | -0.82 |
Net Income | -2.59 | -1.89 | -2.26 | -1.56 |
Period Ending: | Jun 30, 2018 | Dec 31, 2017 | Jun 30, 2017 | Dec 31, 2016 |
---|---|---|---|---|
Total Assets | 3.72 | 4.4 | 4.21 | 4.56 |
Total Liabilities | 10.03 | 7.39 | 7.59 | 6.18 |
Total Equity | -6.31 | -2.99 | -3.38 | -1.62 |
Period Ending: | Jun 30, 2018 | Dec 31, 2017 | Jun 30, 2017 | Dec 31, 2016 |
---|---|---|---|---|
Period Length: | 12 Months | 6 Months | 12 Months | 6 Months |
Cash From Operating Activities | -1.17 | -0.25 | -0.77 | -0.23 |
Cash From Investing Activities | -0.16 | -0.08 | -0.25 | -0.14 |
Cash From Financing Activities | 1.18 | 1.12 | 1.17 | 0.82 |
Net Change in Cash | -0.14 | 0.79 | 0.15 | 0.45 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review